Elderly Chronic Diseases Online Biometric Analysis Home Living Technology (e-COBAHLT)

March 24, 2026 updated by: University Hospital, Limoges

Etude de l'Impact Clinique de la télésurveillance à Domicile Par télémédecine de paramètres biométriques de la Personne âgée Polypathologique

The elderly or people with disabilities want to remain in their homes even when their health condition has been getting worse.

This project aims to demonstrate that home automation and telemonitoring can lead to develop a home safety environment that could help the elderly and individual with disability live independently in their own home.

In this study, the automation sensors containing devices follow up chronic disease clinical factors to monitor their biometrical parameters and detect any abnormal prodromal disease decompensation via telemonitoring and geriatric expertise.

The purpose of this study is:

  • to provide clinical evidence of the effectiveness of automation tools and telemonitoring/expertise for the home support for people at risk of loss of autonomy
  • to demonstrate the clinical benefit of combining the automation and telemonitoring and geriatric teleexpertise

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

536

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Limoges, France, 87042
        • Service de Gériatrie - CHU de LImoges

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 65 or more.
  • House equipped with home automation
  • Having been hospitalized in the year prior to the inclusion for the following conditions : heart failure, chronic obstructive pulmonary disease (COPD ), diabetes, high blood pressure ( hypertension ) , repetitive falls, chronic renal failure , stroke, neurodegenerative diseases , malnutrition (according to criteria HAS)
  • Multiple chronic diseases (at least 2 comorbidities) .
  • Having given free and informed consent

Exclusion Criteria:

  • Life expectancy less than 12 months
  • Enrolled in another clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Biosensors
Participants in this arm are equipped both with home telecare/automation and with biometric sensors
Device: Biosensors
Device: Biometric sensors; Home automation; telecare
Device: Home automation
Active Comparator: Automation
Participants in this arm are equiepd with home automation only
Device: Home automation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of unplanned hospitalization for decompensation
Time Frame: at 12 months
The effectiveness of home telemonitoring on the cumulative incidence of unplanned hospitalization for decompensation in the elderly
at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact on global health
Time Frame: at 12 months
  • Number of visits to the emergency
  • Number of readmissions
  • Number of days of hospitalization
  • Number of visits to the doctor
at 12 months
Cost/effectivness preventive care
Time Frame: at 12 months
Evaluate the cost / effectiveness of the impact of telemonitoring on the preventive care in the elderly
at 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Limoges

Investigators

  • Study Chair: Thierry DANTOINE, MD, CHU Limoges

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2014

Primary Completion (Actual)

September 9, 2018

Study Completion (Actual)

January 1, 2019

Study Registration Dates

First Submitted

May 24, 2014

First Submitted That Met QC Criteria

June 2, 2014

First Posted (Estimated)

June 4, 2014

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

January 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • I13027

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on The Elderly

Clinical Trials on Biosensors

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe